Avanos MedicalAVNS +0.20%62 Current Ratio is 2.48 as of Mar. 2026, which is 9% below its 10-year median of 2.74. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.42 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Avanos Medical ranks worse than 50.12% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Avanos Medical's current ratio for the quarter that ended in Mar. 2026 was 2.48.
Avanos Medical has a current ratio of 2.48. It generally indicates good short-term financial strength.
The historical rank and industry rank for Avanos Medical's Current Ratio or its related term are showing as below:
AVNS'
s Current Ratio Range Over the Past 10 Years
Min: 1.83 Med: 2.74 Max: 3.27
Current: 2.48
During the past 13 years, Avanos Medical's highest Current Ratio was 3.27. The lowest was 1.83. And the median was 2.74.
AVNS's Current Ratio is ranked worse than 50.12% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.485
vs AVNS: 2.48
Avanos Medical (NYSE:AVNS) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Avanos Medical Current Ratio Related Terms
Avanos Medical Current Ratio Historical Data
* Premium members only.
The historical data trend for Avanos Medical's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVNS vs IRMD, TNDM, ATEC: Current Ratio Comparison
For the Medical Devices subindustry, Avanos Medical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Current Ratio distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a Current Ratio of 2.48 as of Mar. 2026. This is near median its historical median of 2.74. Over the past decade, Avanos Medical's Current Ratio has ranged from 1.83 to 3.27. According to the industry distribution chart, Avanos Medical ranks #428 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Avanos Medical's Current Ratio too high?
Avanos Medical's current Current Ratio of 2.48 is near median its 10-year median of 2.74. Over the past 10 years, this metric has ranged from a low of 1.83 to a high of 3.27. The Medical Devices & Instruments industry median Current Ratio is 2.49. Avanos Medical's value of 2.48 is 0.2% below this industry median. Based on the distribution chart, Avanos Medical ranks #428 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Current Ratio compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #428 out of 854 companies for Current Ratio. This places Avanos Medical in the lower half of its industry. The industry median Current Ratio is 2.49. Avanos Medical's value of 2.48 is 0.2% below this benchmark. Historically, Avanos Medical's own Current Ratio has ranged from 1.83 to 3.27 over the past decade. While the company's 10-year median is 2.74 vs. the industry median of 2.49, Avanos Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current Current Ratio of 2.48 is 0.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current Current Ratio is 2.48, which is near median its own 10-year median of 2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.42, compared to a current price of $24.95 — trading 28.5% above its estimated fair value. The current Current Ratio is 2.48, which is near median its 10-year median of 2.74 and 0.2% below the Medical Devices & Instruments industry median of 2.49. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Current Ratio is 2.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.5% above its estimated GF Value™ of $19.42.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
Current Ratio: 2.48 (near median its 10-year median of 2.74)
GF Value™: $19.42 vs. price of $24.95 (28.5% above fair value)
Industry Position: 0.2% below the Medical Devices & Instruments median (#428 of 854)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
